Autoantibodies against oxidized LDL are associated with severe chest pain attacks in patients with coronary heart disease

Free Radical Biology and Medicine

Volumn 39, Issue 12, 2005, Pages 1660-1665

  Luoma, Jukka S ^a,b,c   Kareinen, Anu ^b   Närvänen, Outi ^a   Viitanen, Laura ^b   Laakso, Markku ^b   Ylä Herttuala, Seppo ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c Hameenlinna Central Hospital   (Finland)

Author keywords

Acute coronary syndrome; Antibodies; Coronary disease; Free radicals; Oxidized LDL

Indexed keywords

AUTOANTIBODY; OXIDIZED LOW DENSITY LIPOPROTEIN;

ADULT; AGED; ANAMNESIS; ANGIOCARDIOGRAPHY; ARTICLE; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SIBLING; STATISTICAL SIGNIFICANCE; THORAX PAIN;

ADULT; AGED; AGED, 80 AND OVER; AUTOANTIBODIES; CHEST PAIN; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; SENSITIVITY AND SPECIFICITY;

EID: 27844575162     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2005.08.007     Document Type: Article

References (39)

1. D. Steinberg, and A. Lewis Conner Memorial Lecture: oxidative modification of LDL and atherogenesis Circulation 95 1997 1062 1071
2. C.J. Binder, M.K. Chang, P.X. Shaw, Y.I. Miller, K. Hartvigsen, A. Dewan, and J.L. Witztum Innate and acquired immunity in atherogenesis Nat. Med. 8 2002 1218 1226
3. S. Ylä-Herttuala, W. Palinski, M.E. Rosenfeld, S. Parthasarathy, T.E. Carew, S. Butler, J.L. Witztum, and D. Steinberg Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man J. Clin. Invest. 84 1989 1086 1095
4. S. Ylä-Herttuala, W. Palinski, S.W. Butler, S. Picard, D. Steinberg, and J.L. Witztum Rabbit and human atherosclerotic lesions contain IgG that recognizes epitopes of oxidized LDL Arterioscler. Thromb. 14 1994 32 40
5. J.T. Salonen, S. Ylä-Herttuala, R. Yamamoto, S. Butler, H. Korpela, R. Salonen, K. Nyyssönen, W. Palinski, and J.L. Witztum Autoantibody against oxidised LDL and progression of carotid atherosclerosis Lancet 339 1992 883 887
6. T. Heitzer, S. Ylä-Herttuala, J. Luoma, S. Kurz, T. Munzel, H. Just, M. Olschewski, and H. Drexler Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia: role of oxidized LDL Circulation 93 1996 1346 1353
7. R. Wu, S. Nityanand, L. Berglund, H. Lithell, G. Holm, and A.K. Lefvert Antibodies against cardiolipin and oxidatively modified LDL in 50-year-old men predict myocardial infarction Arterioscler. Thromb. Vasc. Biol. 17 1997 3159 3163
8. A.T. Erkkilä, O. Närvänen, S. Lehto, M.I. Uusitupa, and S. Ylä-Herttuala Autoantibodies against oxidized low-density lipoprotein and cardiolipin in patients with coronary heart disease Arterioscler. Thromb. Vasc. Biol. 20 2000 204 209
9. M.I. Uusitupa, L. Niskanen, J. Luoma, P. Vilja, M. Mercuri, R. Rauramaa, and S. Ylä-Herttuala Autoantibodies against oxidized LDL do not predict atherosclerotic vascular disease in non-insulin-dependent diabetes mellitus Arterioscler. Thromb. Vasc. Biol. 16 1996 1236 1242
10. S.A. Millican, D. Schultz, M. Bagga, P.J. Coussons, K. Muller, and J.V. Hunt Glucose-modified low density lipoprotein enhances human monocyte chemotaxis Free Radic. Res. 28 1998 533 542
11. E. Korpinen, P.H. Groop, H.K. Akerblom, and O. Vaarala Immune response to glycated and oxidized LDL in IDDM patients with and without renal disease Diabetes Care 20 1997 1168 1171
12. M.K. Cathcart Regulation of superoxide anion production by NADPH oxidase in monocytes/macrophages: contributions to atherosclerosis Arterioscler. Thromb. Vasc. Biol. 24 2004 23 28
13. P.M. Ridker Clinical application of C-reactive protein for cardiovascular disease detection and prevention Circulation 107 2003 363 369
14. A. Kareinen, L. Viitanen, P. Halonen, S. Lehto, and M. Laakso Cardiovascular risk factors associated with insulin resistance cluster in families with early-onset coronary heart disease Arterioscler. Thromb. Vasc. Biol. 21 2001 1346 1352
15. World Health Organization Report of a WHO Study Group: diabetes mellitus 1985 WHO Geneva
16. L. Viitanen, J. Pihlajamäki, R. Miettinen, P. Kärkkäinen, I. Vauhkonen, P. Halonen, A. Kareinen, S. Lehto, and M. Laakso Apolipoprotein E gene promoter (-219G/T) polymorphism is associated with premature coronary heart disease J. Mol. Med. 79 2001 732 737
17. Hurst's the heart 2001 McGraw-Hill New York
18. O. Närvänen, A. Erkkilä, and S. Ylä-Herttuala Evaluation and characterization of EIA measuring autoantibodies against oxidized LDL Free Radic. Biol. Med. 31 2001 769 777
19. R. Ross Mechanisms of disease-Atherosclerosis-An inflammatory disease N. Engl. J. Med. 340 1999 115 126
20. P. Libby Molecular bases of the acute coronary syndromes Circulation 91 1995 2844 2850
21. M.J. Davies Paul Dudley White Lecture 1995: stability and instability: two faces of coronary atherosclerosis Circulation 94 1996 2013 2020
22. S. Toshima, A. Hasegawa, M. Kurabayashi, H. Itabe, T. Takano, J. Sugano, K. Shimamura, J. Kimura, I. Michishita, T. Suzuki, and R. Nagai Circulating oxidized low density lipoprotein levels: a biochemical risk marker for coronary heart disease Arterioscler. Thromb. Vasc. Biol. 20 2000 2243 2247
23. J. Hulthe, L. Bokemark, and B. Fagerberg Antibodies to oxidized LDL in relation to intima-media thickness in carotid and femoral arteries in 58-year-old subjectively clinically healthy men Arterioscler. Thromb. Vasc. Biol. 21 2001 101 107
24. P. Holvoet, J. Van Cleemput, D. Collen, and J. Vanhaecke Oxidized low density lipoprotein is a prognostic marker of transplant-associated coronary artery disease Arterioscler. Thromb. Vasc. Biol. 20 2000 698 702
25. T. Lehtimäki, S. Lehtinen, T. Solakivi, M. Nikkilä, O. Jaakkola, H. Jokela, S. Ylä-Herttuala, J.S. Luoma, T. Koivula, and T. Nikkari Autoantibodies against oxidized low density lipoprotein in patients with angiographically verified coronary artery disease Arterioscler. Thromb. Vasc. Biol. 19 1999 23 27
26. R. Wu, U. de Faire, C. Lemne, J.L. Witztum, and J. Frostegard Autoantibodies to OxLDL are decreased in individuals with borderline hypertension Hypertension 33 1999 53 59
27. W. Palinski, E. Miller, and J.L. Witztum Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis Proc. Natl. Acad. Sci. USA 92 1995 821 825
28. G.N. Fredrikson, I. Soderberg, M. Lindholm, P. Dimayuga, K.Y. Chyu, P.K. Shah, and J. Nilsson Inhibition of atherosclerosis in apoE-null mice by immunization with apoB-100 peptide sequences Arterioscler. Thromb. Vasc. Biol. 23 2003 879 884
29. E. Braunwald, E.M. Antman, J.W. Beasley, R.M. Califf, M.D. Cheitlin, J.S. Hochman, R.H. Jones, D. Kereiakes, J. Kupersmith, T.N. Levin, C.J. Pepine, J.W. Schaeffer, E.E. Smith, D.E. Steward III, P. Theroux, R.J. Gibbons, J.S. Alpert, D.P. Faxon, V. Fuster, G. Gregoratos, L.F. Hiratzka, A.K. Jacobs, and S.C. Smith Jr. ACC/AHA 2002 guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction-Summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina) J. Am. Coll. Cardiol. 40 2002 1366 1374
30. American Heart Association Heart disease and stroke statistics-2003 update 2002 American Heart Association Dallas
31. K.A. Fox, D.V. Cokkinos, J. Deckers, U. Keil, A. Maggioni, and G. Steg The ENACT study: a pan-European survey of acute coronary syndromes. European Network for Acute Coronary Treatment Eur. Heart J. 21 2000 1440 1449
32. H. Tunstall-Pedoe, K. Kuulasmaa, M. Mähonen, H. Tolonen, E. Ruokokoski, and P. Amouyel Contribution of trends in survival and coronary-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA project populations. Monitoring trends and determinants in cardiovascular disease Lancet 353 1999 1547 1557
33. Anonymous. First results of the demographic data collection for 2002 in Europe. In: Statistics in focus. Eurostat, European Communities; 2003.
34. British Heart Foundation Health Promotion Research Group European cardiovascular disease statistics 2000 British Heart Foundation Oxford
35. L. Erhardt, J. Herlitz, L. Bossaert, M. Halinen, M. Keltai, R. Koster, C. Marcassa, T. Quinn, and H. van Weert Task force on the management of chest pain Eur. Heart J. 23 2002 1153 1176
36. J. Hulthe, and B. Fagerberg Circulating oxidized LDL is associated with subclinical atherosclerosis development and inflammatory cytokines (AIR study) Arterioscler. Thromb. Vasc. Biol. 22 2002 1162 1167
37. J. Karvonen, M. Päivänsalo, Y.A. Kesäniemi, and S. Hörkko Immunoglobulin M type of autoantibodies to oxidized low-density lipoprotein has an inverse relation to carotid artery atherosclerosis Circulation 108 2003 2107 2112
38. H. Viita, O. Närvänen, and S. Ylä-Herttuala Different apolipoprotein B breakdown patterns in models of oxidized low density lipoprotein Life Sci. 65 1999 783 793
39. S. Ylä-Herttuala Is oxidized low-density lipoprotein present in vivo? Curr. Opin. Lipidol. 9 1998 337 344